A post-marketing database surveillance to investigate the risk of diagnosed lactic acidosis events in MRSA patients treated with tedizolid or linezolid in Japan (MK-1986-046)

First published 14/01/2026

Last updated 14/01/2026

EU PAS number:

EUPAS1000000894

Study

Ongoing

Documents

Study protocol

Initial protocol

MK-1986-046_post-marketing database study_Lactic acidosis_protocol_final-redactiond.pdf

English (1.66 MB - PDF) View document

Study results

Study report

Other information

Secondary tabs